Login to Your Account

Other News To Note

Wednesday, December 4, 2013

• Gland Pharma Ltd., of Mumbai, India, said KKR, a global investment firm, will acquire a minority stake in the generics company for approximately $200 million, including KKR’s acquisition of the entire stake held by Evolvence India Life Sciences Fund, an existing private equity investor in Gland Pharma.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription